VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
VIRX
Delisted
VIRX was delisted on the 3rd of February, 2025.
73 hedge funds and large institutions have $175M invested in Viracta Therapeutics, Inc. Common Stock in 2013 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 23 increasing their positions, 24 reducing their positions, and 11 closing their positions.
Holders
73
Holders Change
–
Holders Change %
0%
% of All Funds
2.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
23
Reduced
24
Closed
11
Calls
$2.28M
Puts
$562K
Net Calls
+$1.72M
Net Calls Change
+$1.49M
Top Buyers
1 |
AP
1
Alydar Partners
Boston,
Massachusetts
|
$2.56M |
2 |
2
Axa
Paris,
France
|
$1.67M |
3 |
FCM
3
Farallon Capital Management
San Francisco,
California
|
$4.98M |
4 |
4
D.E. Shaw & Co
New York
|
$2.65M |
5 |
CI
5
Cowen Inc
New York
|
$3.3M |